Loading…
Loading…
Tender Value
Refer Docs
Closing Date
14 Apr 2026, 11:25 amClosed
Single Packet
Normal Tender
No
Itemwise/Consigneewise
Lowest to Highest
CONSIGNEE
Rly. Board
Expenditure
General
PUR
3 conditions
In line with IRS conditions of contract clause 3204, the decision of the ZR/PU about the salt being substandard will be final and binding on the manufacturing unit or Manufacturing and marketing unit.
The medicines and drugs are reserved to be purchased from firms registered with railway board, New Delhi for supply of medicines and manufacturing unit of the offered product should be inspected and passed fit by railway. However, in case of medical stores other than medicines such as rubber goods, consumables, implants and appliances etc. Not covered under the new drug policy guidelines issued by railway board, the purchaser reserve its right to purchase it from the firms registered with NWR, Jaipur or CMS/DRH/JU, who are either manufacturing, marketing or even distributing agency for the product offered. In such cases the inspection of manufacturing unit is not mandatory.
In case of an imported item attach valid import license issued by competent authority
21 conditions
Please enter the percentage of local content in the material being offered. Please enter 0 for fully imported items, and 100 for fully indigenous items. The definition and calculation of local content shall be in accordance with the make in India policy as incorporated in the tender conditions.
Please write/mention MRP of the offered product.
Hospital supply rate of drug
The bidder confirms that rates and other financial terms quoted in relevant columns of financial bid will only be ruling terms for acceptance, and such terms quoted anywhere else should be ignored.
All the bidders should ensure that they are GST compliant and their quoted tax structure/rates are as per GST law.
Please enter the percentage of local content in the material being offered. Please enter 0 for fully imported items, and 100 for fully indigenous items. The definition and calculation of local content shall be in accordance with the Make in India policy as incorporated in the tender conditions.
As per Implementation of Pharmaceuticals Preferential Purchase Policy over Indian Railways, Procurement of 104 products of CPSEs firms i.e M/s KAPL, M/s HAL & BCPL have been reserved for all central government departments In case Pharma CPSEs and their subsidiaries fail to supply / quote for the medicines, the procuring entity would be at liberty to make purchase from other manufacturers. If the Pharma CPSEs and their subsidiaries fail to perform as per PO, they would also be subject to payment of liquidated damages or any other penalty as per IRS conditions of contract.
1 location across Rajasthan · 1,790 Numbers total
Medicine items
H4261118
H4261118
Limited - Indigenous
Goods
Jodhpur, Rajasthan
₹0
Exempted
14 Apr 2026
7 Apr 2026
3 items · 1,790 Numbers total
Butorphanol tartrate Inj. 2mg/ml 1ml. amp. ]
| Delivery Location | State | Quantity |
|---|---|---|
| JODHPUR DIVISIONAL HOSPITAL, NWR | Rajasthan | 300.00 Numbers |
| Total | 300 Numbers | |
Paracetamol 150mg./ml. Inj. 2ml. amp. (IRP_NO - 65404 as per Drg.No. 65404 ]
| Delivery Location | State | Quantity |
|---|---|---|
| JODHPUR DIVISIONAL HOSPITAL, NWR | Rajasthan | 1290.00 Numbers |
| Total | 1,290 Numbers | |
Nandrolone decanoate Inj. 50mg./ml. 1ml. Amp. (IRP_NO - 00103 as per Drg.No. 103.0 ]
| Delivery Location | State | Quantity |
|---|---|---|
| JODHPUR DIVISIONAL HOSPITAL, NWR | Rajasthan | 200.00 Numbers |
| Total | 200 Numbers | |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
HTML
nit.pdf
NIT
1879794.pdf
ATTACHMENT
2307177.pdf
ATTACHMENT
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at [email protected].